Levy Adam D.
SEC CIK 2061876 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | CFO | 66.0K | $15.0K | $1,793 | 4 | 2025-08-01 | 2026-08-04 |
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 16:34 | 2026-08-04 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | S - Sale | $1.57 | -1,142 | 66.0K | -2% | -$1,793 | |
| 2026-05-20 16:30 | 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | A - Grant | $0.00 | +46.2K | 67.2K | +220% | $0 | |
| 2026-01-16 | 2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | P - Purchase | $1.70 | +8,832 | 21.0K | +73% | +$15.0K | |
| 2025-08-05 | 2025-08-01 | ACRV | Acrivon Therapeutics, Inc. | Levy Adam D. | CFO | F - Tax | $1.26 | -1,164 | 12.2K | -9% | -$1,467 |
Purchase Sale Sale after option exercise All abbreviations